Cannabinoid Receptor Function & Alcoholism

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 9, 2007

Primary Completion Date

June 22, 2010

Study Completion Date

June 22, 2010

Conditions
Alcoholism
Interventions
DRUG

THC

"* High dose: 0.036 mg/kg (2.5 mg in a 70 kg individual)IV (in the vein) dissolved in ethanol. Equivalent to smoking a full joint~* Low dose: 0.018 mg/kg (1.25 mg in a 70kg individual) IV (in the vein) dissolved in ethanol.Equivalent to smoking ½ of a joint~* Very low dose: 0.0036 mg/kg (0.25 mg in a 70 kg individual)IV (in the vein) dissolved in ethanol. Equivalent to smoking 1/10 of a joint"

DRUG

Placebo

Placebo: Small amount of ethanol IV (in the vein), (quarter teaspoon).

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT00624715 - Cannabinoid Receptor Function & Alcoholism | Biotech Hunter | Biotech Hunter